Munafa Stock Market Course + Intraday & FNO calls 
543311 NEWS why is Ipl price falling or rising
543311 NEWS reasons for why stock price of Ipl is falling or rising
543311 Ipl is falling or rising technical reasons
Technical analysis forecast for Ipl Stock is that its in a downtrend for shortterm, and I will avoid taking a BUY or a LONG trade in this stock. Look for opportunities to sell or SHORT Ipl 543311 at this time. Stock is falling and might fall more.
It appears as if Ipl 543311 gave a large move recently.
Stock of Ipl (543311) is trading below an important moving average line, and it has been below this line for quite some time now. This is not a good sign, stock might keep falling and stock might move lower...
My analysis of Ipl is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if Ipl stays below 173, but if it comes above 173, then a intra day buy could be more profitable.
If you take a sell trade below 173, then use 173 as stoploss and 166.4 as target. However if you take a buy trade in Ipl, then use 173 as stoploss and 178.52 as target.
543311 Ipl is falling or rising NEWS fundamental reasons
Lupin gets USFDA nod for multiple sclerosis drug Drug maker Lupin has secured approval from the US health regulator for its generic multiple sclerosis treatment. The company received tentative approval from the USFDA for Siponimod Tablets. This new product will be manufactured at Lupin's Pithampur facili - NEWS as on 2025-12-05 indiatimes.com
Equity, gold, debt and discipline: Key ingredients for wedding financial planning through mutual funds Wedding season is here and costs are rising. Financial expert Pankaj Mathpal shares tips for planning wedding expenses. He stresses starting early and investing wisely. Equity and gold are recommended for long-term growth. For those who missed early planni - NEWS as on 2025-12-04 indiatimes.com
DGCA probing Air India operating A320 neo plane multiple times without airworthiness certification India’s aviation regulator (DGCA) has said Air India operated an Airbus A320 without a valid Airworthiness Review Certificate, flying it eight times after the certificate expired. The aircraft has since been grounded, and the DGCA has launched an investiga - NEWS as on 2025-12-02 indiatimes.com
LIC uses Cipla’s dip as entry point, raises stake by 2% to 7.05% LIC increased its stake in Cipla to 7.055% by acquiring 2.03% shares between July 17 and November 27. The purchase comes as Cipla trades near key SMAs, posts modest Q2 growth, and gains a ‘Buy’ rating from Sharekhan. - NEWS as on 2025-12-01 indiatimes.com
7 equity funds offer over 25% CAGR in multiple timeframes. Are they part of your portfolio? Seven top-performing equity mutual funds, including Bandhan Small Cap and HDFC Mid Cap, have delivered over 25% CAGR across three- and five-year periods, making them standout long-term performers. - NEWS as on 2025-11-29 indiatimes.com
Cipla launches India's first dedicated lung health diagnostics centre Cipla has opened India's first integrated lung diagnostics and wellness centre in Lajpat Nagar, Delhi. This facility offers over 60 tests for comprehensive respiratory care. It aims to make advanced lung diagnostics accessible and affordable for all. - NEWS as on 2025-11-28 indiatimes.com
Sharekhan bullish despite pharma's underperformance; backs Cipla, Lupin & 3 more for up to 16% gains Despite pharma’s one-year underperformance, Sharekhan sees strong revenue growth and identifies five top stocks with 9–16% upside potential. - NEWS as on 2025-11-27 indiatimes.com
Safran to triple its India ops revenue to over €3 billion by 2030 French aerospace giant Safran is set to significantly boost its presence in India. The company aims to triple its revenue to over three billion euros by 2030. Safran will also quintuple its sourcing from India. New facilities in Hyderabad for engine mainte - NEWS as on 2025-11-26 indiatimes.com
Glenmark launches fixed-dose triple therapy for COPD Glenmark Pharmaceuticals has launched a groundbreaking nebulised triple therapy for COPD. This single, easy-to-use treatment combines three medicines to improve lung function and symptom control. It offers a new standard of care, especially for patients wh - NEWS as on 2025-11-25 indiatimes.com
More announcements and NEWS
543311 Ipl current price & indicator signals
Recent prices of 543311 Ipl are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 05 Fri Dec 2025 | 172.45 | 169.30 to 173.20 | 0.88% | 1.68 times |
| 04 Thu Dec 2025 | 170.95 | 169.55 to 173.00 | -0.7% | 1.32 times |
| 03 Wed Dec 2025 | 172.15 | 171.00 to 175.05 | -1.09% | 3.34 times |
| 02 Tue Dec 2025 | 174.05 | 173.00 to 178.95 | -1.72% | 1 times |
| 01 Mon Dec 2025 | 177.10 | 176.20 to 178.70 | -0.51% | 0.83 times |
| 28 Fri Nov 2025 | 178.00 | 175.10 to 179.45 | -0.08% | 0.72 times |
| 27 Thu Nov 2025 | 178.15 | 176.55 to 178.55 | 0.79% | 0.13 times |
| 26 Wed Nov 2025 | 176.75 | 175.65 to 180.15 | 0.6% | 0.57 times |
| 25 Tue Nov 2025 | 175.70 | 171.95 to 176.55 | 1.59% | 0.41 times |
| 24 Mon Nov 2025 | 172.95 | 171.05 to 175.35 | -1.42% | 0.91 times |
| 21 Fri Nov 2025 | 175.45 | 173.00 to 176.40 | -0.45% | 0.78 times |
| 20 Thu Nov 2025 | 176.25 | 176.00 to 178.45 | -0.82% | 2.32 times |
Videos related to: 543311 NEWS why is Ipl price falling or rising
Hindi Basics How To Trade In FnO Futures Options Stock Market
- BSE Screeners
- BSE Daily Screener
- BSE Weekly Screener
- BSE Monthly Screener
- Support & Resistance
- BSE Shares Near Support
- BSE Shares Near Resistance
